Ubs Group Ag Kamada LTD Transaction History

Ubs Group Ag

$555 Billion
Q2 2025

A detailed history of Ubs Group Ag transactions in Kamada LTD stock. As of the latest transaction made, Ubs Group Ag holds 46,765 shares of KMDA stock, worth $349,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,765

Previous 5,591 736.43%

Holding current value

$349,802

Previous $36,000 905.56%

% of portfolio

0.0%

Previous 0.0%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$5.76 - $8.12 $237,162 - $334,332	41,174 Added 736.43%	46,765 $362,000
Q1 2025 May 13, 2025	SELL	$6.33 - $8.33 $49,601 - $65,273	-7,836 Reduced 58.36%	5,591 $36,000
Q4 2024 Feb 14, 2025	BUY	$5.17 - $6.27 $69,417 - $84,187	13,427 New	13,427 $81,000
Q2 2024 Aug 13, 2024	SELL	$4.78 - $5.75 $91,833 - $110,469	-19,212 Reduced 98.58%	276 $1,000
Q1 2024 May 13, 2024	SELL	$5.58 - $6.42 $312,067 - $359,044	-55,926 Reduced 74.16%	19,488 $109,000
Q4 2023 Feb 09, 2024	BUY	$4.14 - $6.22 $302,534 - $454,532	73,076 Added 3125.58%	75,414 $461,000
Q3 2023 Nov 09, 2023	BUY	$4.86 - $5.83 $11,362 - $13,630	2,338 New	2,338 $12,000
Q1 2023 May 12, 2023	BUY	$4.12 - $5.25 $194,698 - $248,099	47,257 Added 8984.22%	47,783 $221,000
Q4 2022 Feb 08, 2023	SELL	$3.79 - $4.84 $9,183 - $11,727	-2,423 Reduced 82.16%	526 $2,000
Q3 2022 Nov 10, 2022	BUY	$4.42 - $5.43 $2,249 - $2,763	509 Added 20.86%	2,949 $13,000
Q2 2022 Aug 10, 2022	BUY	$4.22 - $5.85 $7,958 - $11,033	1,886 Added 340.43%	2,440 $11,000
Q1 2022 May 16, 2022	SELL	$5.43 - $6.81 $14,807 - $18,570	-2,727 Reduced 83.11%	554 $3,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $6.82 $17,094 - $22,376	3,281 New	3,281 $22,000
Q3 2021 Nov 15, 2021	SELL	$5.25 - $5.87 $73,893 - $82,620	-14,075 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$5.67 - $6.33 $70,529 - $78,738	12,439 Added 760.33%	14,075 $82,000
Q1 2021 May 12, 2021	SELL	$6.02 - $8.06 $317,374 - $424,923	-52,720 Reduced 96.99%	1,636 $10,000
Q4 2020 Feb 11, 2021	SELL	$6.3 - $8.46 $249,303 - $334,779	-39,572 Reduced 42.13%	54,356 $352,000
Q3 2020 Nov 12, 2020	BUY	$8.02 - $11.73 $34,750 - $50,826	4,333 Added 4.84%	93,928 $785,000
Q2 2020 Jul 31, 2020	BUY	$5.37 - $9.45 $80,383 - $141,457	14,969 Added 20.06%	89,595 $695,000
Q1 2020 May 01, 2020	BUY	$4.56 - $7.13 $36,958 - $57,788	8,105 Added 12.18%	74,626 $435,000
Q4 2019 Feb 14, 2020	BUY	$4.97 - $7.7 $320,405 - $496,403	64,468 Added 3140.19%	66,521 $454,000
Q3 2019 Nov 14, 2019	BUY	$5.11 - $5.99 $10,490 - $12,297	2,053 New	2,053 $11,000
Q1 2019 May 14, 2019	SELL	$5.12 - $6.18 $17,387 - $20,987	-3,396 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$4.68 - $6.25 $987 - $1,318	211 Added 6.62%	3,396 $17,000
Q3 2018 Nov 14, 2018	BUY	$5.15 - $6.3 $1,972 - $2,412	383 Added 13.67%	3,185 $20,000
Q2 2018 Aug 14, 2018	SELL	$4.4 - $5.3 $787 - $948	-179 Reduced 6.0%	2,802 $15,000
Q1 2018 May 15, 2018	BUY	$4.6 - $5.75 $12,332 - $15,415	2,681 Added 893.67%	2,981 $14,000
Q4 2017 Feb 14, 2018	BUY	$4.35 - $5.15 $1,305 - $1,545	300 New	300 $1,000
Q3 2017 Nov 14, 2017	SELL	$4.25 - $4.8 $2,805 - $3,168	-660 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	561 Added 566.67%	660 $4,000
Q1 2017 Nov 14, 2017	BUY	N/A	99	99 $1,000

Others Institutions Holding KMDA

# of Institutions

Shares Held

5.8M

Call Options Held

21K

Put Options Held

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $335M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account